Skip to content
Screener

Neogen NEOG Operating Income

Operating Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.09B
Idexx Laboratories logo
Idexx LaboratoriesIDXX
$425.57M+14.1%
Revvity logo
RevvityRVTY
$75.89M+5.1%
TEC
Bio-TechneTECH
$75.5M+95.0%
Agilent Technologies logo
Agilent TechnologiesA
$399M+33.0%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$44.65M+33.2%

Segments

By segment

See full
Food Safety$16.3M-15.5%
Animal Safety$5.7M-16.2%

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2.46B+138%
Enterprise value$3.1B+70.0%
P/S2.8×+1.7×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Neogen’s 10-Q, filed April 9, 2026.

Filed
Apr 9, 2026, 4:03 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-149599
Line itemThree months ended February 28, 2026Three months ended February 28, 2025Nine months ended February 28, 2026Nine months ended February 28, 2025
Goodwill impairment461.4
Research and development3.84.513.514.8
Total Operating Expenses102.3104.9325.4778.3
Operating Loss (Income)(3.3)5.4(24.7)(449.8)
Other (Expense) Income
Interest expense, net(13.9)(17.0)(43.7)(52.0)
Gain on sale of business76.4
Other, net(3.1)1.9(4.9)(0.1)

Item 1. Interim Condensed Consolidated Financial Statements

FAQ

What is Neogen's operating income?
Neogen (NEOG) reported operating income of -$3.3M in Q4 2025.
How has Neogen's operating income changed year-over-year?
Neogen's operating income decreased by 161.1% year-over-year, from $5.4M to -$3.3M.
What is the long-term trend for Neogen's operating income?
Over 3 years (2022 to 2025), Neogen's operating income has grown at a 162.6% compound annual growth rate (CAGR), from $58.62M to -$1.06B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Neogen's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude